These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18183595)

  • 1. Rectal gastrointestinal stromal tumors associated with a novel germline KIT mutation.
    Woźniak A; Rutkowski P; Sciot R; Ruka W; Michej W; Debiec-Rychter M
    Int J Cancer; 2008 May; 122(9):2160-4. PubMed ID: 18183595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation.
    Graham J; Debiec-Rychter M; Corless CL; Reid R; Davidson R; White JD
    Arch Pathol Lab Med; 2007 Sep; 131(9):1393-6. PubMed ID: 17824795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13.
    Bachet JB; Landi B; Laurent-Puig P; Italiano A; Le Cesne A; Lévy P; Safar V; Duffaud F; Blay JY; Emile JF
    Eur J Cancer; 2013 Jul; 49(11):2531-41. PubMed ID: 23648119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
    Lasota J; Miettinen M
    Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
    Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
    Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling.
    Tarn C; Merkel E; Canutescu AA; Shen W; Skorobogatko Y; Heslin MJ; Eisenberg B; Birbe R; Patchefsky A; Dunbrack R; Arnoletti JP; von Mehren M; Godwin AK
    Clin Cancer Res; 2005 May; 11(10):3668-77. PubMed ID: 15897563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis.
    Lee JH; Kim Y; Choi JW; Kim YS
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):413-8. PubMed ID: 24369323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate.
    Yeh CN; Chen TW; Wu TJ; Hsueh S; Jan YY
    World J Gastroenterol; 2006 Jun; 12(23):3760-5. PubMed ID: 16773696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and multiple gastrointestinal stromal tumors with fair response to a half-dose of imatinib.
    Bamba S; Hirota S; Inatomi O; Ban H; Nishimura T; Shioya M; Imaeda H; Nishida A; Sasaki M; Murata S; Andoh A
    Intern Med; 2015; 54(7):759-64. PubMed ID: 25832938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant imatinib in a locally advanced gastrointestinal stromal tumour (GIST) of the rectum: a rare case of two GISTs within a family without a familial GIST syndrome.
    Mandalà M; Pezzica E; Tamborini E; Guerra U; Lagonigro SM; Forloni B; Barni S
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):711-3. PubMed ID: 17625442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y.
    Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E
    Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing.
    Künstlinger H; Huss S; Merkelbach-Bruse S; Binot E; Kleine MA; Loeser H; Mittler J; Hartmann W; Hohenberger P; Reichardt P; Büttner R; Wardelmann E; Schildhaus HU
    Am J Surg Pathol; 2013 Nov; 37(11):1648-59. PubMed ID: 24061512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors.
    Künstlinger H; Binot E; Merkelbach-Bruse S; Huss S; Wardelmann E; Buettner R; Schildhaus HU
    Hum Pathol; 2014 Mar; 45(3):573-82. PubMed ID: 24444465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial gastrointestinal stromal tumor syndrome: report of 2 cases with KIT exon 11 mutation.
    Jones DH; Caracciolo JT; Hodul PJ; Strosberg JR; Coppola D; Bui MM
    Cancer Control; 2015 Jan; 22(1):102-8. PubMed ID: 25504284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital.
    Yeh CN; Chen TW; Lee HL; Liu YY; Chao TC; Hwang TL; Jan YY; Chen MF
    Ann Surg Oncol; 2007 Mar; 14(3):1123-8. PubMed ID: 17195905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in gastrointestinal stromal tumors diagnosed by endoscopic ultrasound-guided fine needle aspiration.
    Schmitt FC; Gomes AL; Milanezi F; Reis R; Bardales RH
    Minerva Med; 2007 Aug; 98(4):385-8. PubMed ID: 17921955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.
    Yeh CN; Chen TW; Tseng JH; Liu YY; Wang SY; Tsai CY; Chiang KC; Hwang TL; Jan YY; Chen MF
    J Surg Oncol; 2010 Nov; 102(6):599-603. PubMed ID: 20976730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical role of mutation analysis for imatinib treatment in patients with advanced gastrointestinal stromal tumors: a meta-analysis.
    Zhi X; Zhou X; Wang W; Xu Z
    PLoS One; 2013; 8(11):e79275. PubMed ID: 24223922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.
    Mussi C; Schildhaus HU; Gronchi A; Wardelmann E; Hohenberger P
    Clin Cancer Res; 2008 Jul; 14(14):4550-5. PubMed ID: 18628470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.